Sign in

NCT04791865Completed

Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to inform scale-up and sustainability of pediatric disclosure.

Status (registry)
Completed
Study type
Interventional
Enrollment
748 (actual)
First submitted
5 Mar 2021
Start date
15 Jun 2021
Primary completion date
31 Dec 2025
Lead sponsor
Boston University
Diseases
HIV
NCT number
NCT04791865

What you commit to

  • Study type: Interventional
  • Participants enrolled: 748
  • From 15 Jun 2021 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • HIV-infected children less than 7 years
  • HIV-infected children with congenital or developmental disorders
  • HIV-infected children with comorbidities such as sickle cell disease or diabetes that require frequent clinic visits or hospitalizations
  • Children with AIDS-defining illness or end stage AIDS.

Who the study is looking for

  • HIV infected children
  • Children between the ages of 7-18 who do not know their HIV diagnosis (based on caregiver account and medical records confirmation) and their caregivers will be eligible to participate in the study

Age in the registry: 7 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Korle Bu Teaching Hospital
Coordinator of this site? Confirm its status
AccraGhanaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.